Drug-drug interactions with direct-acting antivirals — less is more

키워드

참고문헌 (11)

2. Tommaso Lorenzo Parigi, "Upcoming direct acting antivirals for hepatitis C patients with a prior treatment failure", Clinical and Molecular Hepatology, 25(4), pp.360~365 (2019), 대한간학회
3. 고순영, "Management of hepatitis C viral infection in chronic kidney disease patients on hemodialysis in the era of direct-acting antivirals", Clinical and Molecular Hepatology, 24(4), pp.351~357 (2018), 대한간학회
4. Chung-Feng Huang, "Unmet needs of chronic hepatitis C in the era of direct-acting antiviral therapy", Clinical and Molecular Hepatology, 26(3), pp.251~260 (2020), 대한간학회[DOI]
5. Subramaniam S, "Impact of diabetes mellitus and hepatitis B virus coinfection on patients with chronic hepatitis C: a territory-wide cohort study", J Gastroenterol Hepatol, 33, pp.934~941 (2018)
6. Po-Yao Hsu, "Comedications and potential drug-drug interactions with direct-acting antivirals in hepatitis C patients on hemodialysis", Clinical and Molecular Hepatology, 27(1), pp.186~196 (2021), 대한간학회[DOI]
7. Fabrizi F, "Transmission of hepatitis C virus in dialysis units:a systematic review of reports on outbreaks", Int J Artif Organs, 38, pp.471~480 (2015)
8. He YL, "Safety and efficacy of sofosbuvir-based treatment of acute hepatitis C in endstage renal disease patients undergoing haemodialysis", Aliment Pharmacol Ther, 47, pp.526~532 (2018)
9. Desmond Y. H. Yap, "Use of glecaprevir", pibrentasvir in patients with chronic hepatitis C virus infection and severe renal impairment, 2020, pp.26(4), 554~561[DOI]
10. Li PK, "2018 Kidney disease: improving global outcomes (KDIGO)hepatitis C in chronic kidney disease guideline implementation: Asia summit conference report", Kidney Int Rep, 5, pp.1129~1138 (2020)
11. Wong GL, "Change in treatment paradigm in people who previously injected drugs with chronic hepatitis C in the era of direct-acting antiviral therapy", J Gastroenterol Hepatol, 34, pp.1641~1647 (2019)

관련 논문AI추천